Neil Brewis is CHIEF SCIENTIFIC OFFICER of F-star Therapeutics, Inc.. Currently has a direct ownership of 0 shares of FSTX, which is worth approximately $0. The most recent transaction as insider was on Mar 08, 2023, when has been sold 105,088 shares (Common Stock) at a price of $7.12 per share, resulting in proceeds of $748,226. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Neil Brewis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$748,226 $7.12 p/Share
105,088 Reduced 91.81%
9,375 Common Stock
Mar 08 2023
SELL
Sale (or disposition) back to the issuer
$66,750 $7.12 p/Share
9,375 Reduced 100.0%
0 Common Stock
Jul 29 2022
BUY
Exercise of conversion of derivative security
$8,428 $0.11 p/Share
76,619 Added 40.1%
114,463 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
18,000 Added 32.23%
37,844 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
-
19,844 Added 50.0%
19,844 Common Stock
NB

Neil Brewis

CHIEF SCIENTIFIC OFFICER
Cambridge, X0

Track Institutional and Insider Activities on FSTX

Follow F-star Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FSTX shares.

Notify only if

Insider Trading

Get notified when an F Star Therapeutics, Inc. insider buys or sells FSTX shares.

Notify only if

News

Receive news related to F-star Therapeutics, Inc.

Track Activities on FSTX